| Biography | Ken Marlow is a partner at Waller Lansden and practices in the areas of mergers and acquisitions, securities, corporate law and governance. His practice focuses on the healthcare industry, and he has extensive experience covering a diverse array of corporate transactions, including acquisitions, divestitures and joint ventures; venture capital; and private equity investments. Mr. Marlow recently was appointed to the Board of Directors of Leadership Health Care as a result of his strong practice in the healthcare industry. He also heads Waller Lansden's home health and hospice initiative. Bringing a responsive, pragmatic approach to client representation, Mr. Marlow has assisted healthcare companies in hundreds of transactions, including the development, syndication, acquisition and divestiture of home health companies, hospices, hospitals, outpatient surgery centers and dialysis centers. Recently, Mr. Marlow led a team in representing a private equity company in connection with its $300 million acquisition of a home health company. Mr. Marlow also has broad securities law experience, including underwritten public securities offerings involving both equity and debt, as well as private placement offerings. Mr. Marlow serves as securities counsel for a Fortune 500 company with a market cap of $7 billion and also assists clients with their periodic public reporting under the Securities Exchange Act of 1934. Additionally, Mr. Marlow counsels companies and their boards of directors with respect to some of the most difficult and sensitive corporate disclosure, governance and policy issues, including compliance with the Sarbanes-Oxley Act. Clerkships and Previous Affiliations: Judicial Clerk to the Honorable Bailey Brown, Senior Judge United States Court of Appeals for the Sixth Circuit, 1996-1997. Professional Activities: Board of Directors, Leadership Health Care; Member, Nashville, Tennessee and American Bar Associations; Member, Business Law and Health Law Sections of the American Bar Association; Member, American Health Lawyers Association. Civic and Other Activities: Member, Board of Directors of the Cystic Fibrosis Foundation; Member, National Kidney Foundation of Middle Tennessee; Firm Co-Chair for Habitat for Humanity Home Construction. Articles: 11/19/2010, Getting to Know You: CMS Releases Final Regulations Regarding the Face-to-Face Encounter Requirements for Home Health Agencies; 11/9/2010, CMS Adopts Final Rule Clarifying Home Health Agency 36 Month Rule; 8/23/2010, Good Intentions Gone Wrong: CMS Proposes New Rule to Clarify Home Health Agency 36 Month Rule; 11/24/2009, The Wait is Over: CMS Makes Downward Adjustments to Reimbursement Rates for Home Health Agencies and Restricts Transfers of Provider Agreements; 10/26/2009, Independence at Home Amendment Added to America's Healthy Future Act of 2009; 8/4/2008, Congress Overrides President to Adopt Major End Stage Renal Disease Payment Reform; 6/14/2006, Market basket approach to ESRD payment remains elusive despite MedPAC recommendation as seen in Nephrology News & Issues June 2006 ed.; 3/17/2006, MedPAC Recommends 2.65% Payment Increase to Dialysis Providers; 1/21/2005, MedPAC Recommends Extending Stark Moratorium on Specialty Hospitals; 8/19/2004, SEC Amendments to Form 8-K Become Effective. |